Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with one of these specific cancer types: bladder/urinary tract cancer (urothelial carcinoma), kidney cancer, prostate cancer, cancers of the mouth/throat/upper airway area, cervical cancer, uterine (endometrial) cancer, skin melanoma, soft tissue sarcoma, or testicular germ cell tumors
- People whose cancer has spread to other parts of the body (metastatic disease) and who have not yet started treatment for this stage of the disease
- People aged 18 or older
- People enrolled in the French Social Security system
- People who have signed a consent form agreeing to take part before any study-related procedures begin
Who may not be able to join:
- People whose cancer has not spread and remains in one localised area
- People who are pregnant or currently breastfeeding
- People whose personal, family, psychological, geographical, or social situation may make it difficult to follow the study's required procedures and appointments
- People who are under legal guardianship, court protection, or whose personal freedoms are restricted by an administrative or legal order
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0033 5 31 15 51 70
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of patients presenting blood circulating DP cells detected by at least one of the two tested techniques (Flow Cytometry/ CellSearch® or Parsortix® according to the type of tumor)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.